Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul 19:9:932304.
doi: 10.3389/fvets.2022.932304. eCollection 2022.

Systematic Review on Crimean-Congo Hemorrhagic Fever Enzootic Cycle and Factors Favoring Virus Transmission: Special Focus on France, an Apparently Free-Disease Area in Europe

Affiliations

Systematic Review on Crimean-Congo Hemorrhagic Fever Enzootic Cycle and Factors Favoring Virus Transmission: Special Focus on France, an Apparently Free-Disease Area in Europe

Célia Bernard et al. Front Vet Sci. .

Abstract

Crimean-Congo hemorrhagic fever (CCHF) is a viral zoonotic disease resulting in hemorrhagic syndrome in humans. Its causative agent is naturally transmitted by ticks to non-human vertebrate hosts within an enzootic sylvatic cycle. Ticks are considered biological vectors, as well as reservoirs for CCHF virus (CCHFV), as they are able to maintain the virus for several months or even years and to transmit CCHFV to other ticks. Although animals are not symptomatic, some of them can sufficiently replicate the virus, becoming a source of infection for ticks as well as humans through direct contact with contaminated body fluids. The recent emergence of CCHF in Spain indicates that tick-human interaction rates promoting virus transmission are changing and lead to the emergence of CCHF. In other European countries such as France, the presence of one of its main tick vectors and the detection of antibodies targeting CCHFV in animals, at least in Corsica and in the absence of human cases, suggest that CCHFV could be spreading silently. In this review, we study the CCHFV epidemiological cycle as hypothesized in the French local context and select the most likely parameters that may influence virus transmission among tick vectors and non-human vertebrate hosts. For this, a total of 1,035 articles dating from 1957 to 2021 were selected for data extraction. This study made it possible to identify the tick species that seem to be the best candidate vectors of CCHFV in France, but also to highlight the importance of the abundance and composition of local host communities on vectors' infection prevalence. Regarding the presumed transmission cycle involving Hyalomma marginatum, as it might exist in France, at least in Corsica, it is assumed that tick vectors are still weakly infected and the probability of disease emergence in humans remains low. The likelihood of factors that may modify this equilibrium is discussed.

Keywords: CCHF; France; Hyalomma tick vectors; vertebrate host communities; viral transmission cycle.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Workflow summarizing the steps taken to classify the different articles in the literature and to select the categories of interest for our study.
Figure 2
Figure 2
Presumed enzootic transmission cycle of CCHFV in France, involving the candidate tick vector H. marginatum and its different vertebrate hosts. Animals are represented in different sizes according to relative host preferences of H. marginatum. The ability of these animals to replicate CCHFV is indicated by “+” for good CCHFV amplifiers and “–” for bad CCHFV amplifiers.
Figure 3
Figure 3
Scheme representing factors that may impact either the exposure of animals to tick vectors or the CCHFV infection level of tick vectors, which could finally influence the CCHFV enzootic transmission in France.

References

    1. Papa A. Emerging arboviruses of medical importance in the Mediterranean region. J Clin Virol. (2019) 115:5–10. 10.1016/j.jcv.2019.03.007 - DOI - PubMed
    1. Ergönül Ö. Crimean-Congo haemorrhagic fever. Lancet Infect Dis. (2006) 6:203–14. 10.1016/S1473-3099(06)70435-2 - DOI - PMC - PubMed
    1. Khan JA, Rehman S, Fisher-Hoch SP, Mirza S, Khurshid M, McCormick JB. Crimean congo-haemorrhagic fever treated with oral ribavirin. Lancet. (1995) 346:472–5. 10.1016/S0140-6736(95)91323-8 - DOI - PubMed
    1. Öncü S. Crimean-Congo hemorrhagic fever: an overview. Virol Sin. (2013) 28:193–201. 10.1007/s12250-013-3327-4 - DOI - PMC - PubMed
    1. Yaqub T, Oneeb M, Mukhtar N, Tahir Z, Shahid F, Subhan S, et al. Crimean–Congo Haemorrhagic Fever: case study analysis of a sporadic outbreak from Chakwal, Pakistan. Zoonoses Public Health. (2019) 66:871–3. 10.1111/zph.12623 - DOI - PubMed

Publication types

LinkOut - more resources